Preventicus GmbH, based in Bensheim, develops point-of-care diagnostics using its QuantOn app-based test reader.
Founded in 2014 in Bensheim, Germany, Preventicus GmbH develops point-of-care diagnostics for gastroenterology, oncology, infectious diseases and reproductive medicine. Its QuantOn technology evaluates lateral flow rapid tests through an app that scans and measures results, with products including vitamin D and colon cancer tests. Revenue comes from sales to healthcare facilities and consumers, and the company reported EUR 2,190,767 in 2023. Its latest Seed round raised EUR 1.000 mn from High-Tech Gruenderfonds and D11Z.Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in